| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0003253> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0019693> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0019704> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0020852> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0020854> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0020855> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0020856> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0020857> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0020858> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0020859> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0020860> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0032496> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0033522> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0243009> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0376565> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0475463> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C0728914> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C4505456> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/34438069_HAS_TOPIC_C5398043>
?:authorAffiliation	[\'The Infectious Diseases Unit, Sheba Medical Centre, Tel-Hashomer, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Israel. Electronic address: itsik.levy@sheba.health.gov.il.\', \'The Infectious Diseases Unit, Sheba Medical Centre, Tel-Hashomer, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Israel.\', \'The Infectious Diseases Unit, Sheba Medical Centre, Tel-Hashomer, Israel.\', \'Central Virology Laboratory, Ministry of Health and Sheba Medical Centre, Tel-Hashomer, Israel.\', \'Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Centre, Tel-Hashomer, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Israel; Central Virology Laboratory, Ministry of Health and Sheba Medical Centre, Tel-Hashomer, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Israel; The Infection Prevention & Control Unit, Sheba Medical Centre, Tel Hashomer, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Israel; Nephrology Department, Sheba Medical Centre, Tel-Hashomer, Israel.\', \'The Infection Prevention & Control Unit, Sheba Medical Centre, Tel Hashomer, Israel.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Biber_Asaf> <https://research.tib.eu/covid-19/entity/Cohen_Carmit> <https://research.tib.eu/covid-19/entity/Goldstein_May> <https://research.tib.eu/covid-19/entity/Hod_Tammy> <https://research.tib.eu/covid-19/entity/Huppert_Amit> <https://research.tib.eu/covid-19/entity/Indenbaum_Victoria> <https://research.tib.eu/covid-19/entity/Levin_Einav_Gal> <https://research.tib.eu/covid-19/entity/Levy_Itzchak> <https://research.tib.eu/covid-19/entity/Litchevsky_Vladyslav> <https://research.tib.eu/covid-19/entity/Lustig_Yaniv> <https://research.tib.eu/covid-19/entity/Mor_Orna> <https://research.tib.eu/covid-19/entity/Olmer_Liraz> <https://research.tib.eu/covid-19/entity/Rahav_Galia> <https://research.tib.eu/covid-19/entity/Wieder-Finesod_Anat>
?:doi	S1198-743X(21)00423-710.1016/j.cmi.2021.07.031
?:doi	<https://research.tib.eu/covid-19/entity/S1198-743X%2821%2900423-710.1016/j.cmi.2021.07.031>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34438069>
?:pmid	<https://research.tib.eu/covid-19/entity/34438069>
?:pmid	34438069
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'The Infectious Diseases Unit, Sheba Medical Centre, Tel-Hashomer, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Israel. Electronic address: itsik.levy@sheba.health.gov.il.\', \'The Infectious Diseases Unit, Sheba Medical Centre, Tel-Hashomer, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Israel.\', \'The Infectious Diseases Unit, Sheba Medical Centre, Tel-Hashomer, Israel.\', \'Central Virology Laboratory, Ministry of Health and Sheba Medical Centre, Tel-Hashomer, Israel.\', \'Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Centre, Tel-Hashomer, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Israel; Central Virology Laboratory, Ministry of Health and Sheba Medical Centre, Tel-Hashomer, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Israel; The Infection Prevention & Control Unit, Sheba Medical Centre, Tel Hashomer, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Israel; Nephrology Department, Sheba Medical Centre, Tel-Hashomer, Israel.\', \'The Infection Prevention & Control Unit, Sheba Medical Centre, Tel Hashomer, Israel.\']

?:citedBy